NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|109895563|gb|ABG47527|]
View 

recombination activating protein 2, partial [Pterocryptis anomala]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
RAG2 super family cl28748
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
6-307 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


The actual alignment was detected with superfamily member pfam03089:

Pssm-ID: 427128  Cd Length: 339  Bit Score: 540.86  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563    6 PECYLIHGGRTPNNELSSSLYLLSVDSRGcNRKVIMRCQEKELVGALPEARYGHTLSVVHSRGKTACVLFGGRSYMPPSE 85
Cdd:pfam03089  38 KEQYLIHGGKTPNNELSDKLYIMSLDSKG-NKKVTLRCTEKELVGDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQ 116
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563   86 RTTETWNCMVDCPPQIYLIDLEFGCCSAHAVPELTDGQSFHLALAREDCVYLLGGHIASTDCRPPRLFRVRVELLLGSPL 165
Cdd:pfam03089 117 RTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSLARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPA 196
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563  166 VSCEILNDGLSITSAIATPIGSaHEYIILGGYQSDSQKRLLCTYIGLDDVGIRIEPREPPEWTSEISQSRTWFGGTLAKG 245
Cdd:pfam03089 197 VSCTVLPGGISVSSAIVTQTGS-HEFVIVGGYQSESQKRMVCNTVVLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKG 275
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 109895563  246 SALIVIPTGTNPTPADANYFYQLSFKQ-ERDGEDPTQTCSQEST-DFEDSAPLEDSEELYFGRE 307
Cdd:pfam03089 276 AVLLGIPGDNKQLPSDANYFYQLNFGEdEEEEEQPTQTCSQESTeDQGDSTPFEDSEEFYFSRE 339
 
Name Accession Description Interval E-value
RAG2 pfam03089
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
6-307 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


Pssm-ID: 427128  Cd Length: 339  Bit Score: 540.86  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563    6 PECYLIHGGRTPNNELSSSLYLLSVDSRGcNRKVIMRCQEKELVGALPEARYGHTLSVVHSRGKTACVLFGGRSYMPPSE 85
Cdd:pfam03089  38 KEQYLIHGGKTPNNELSDKLYIMSLDSKG-NKKVTLRCTEKELVGDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQ 116
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563   86 RTTETWNCMVDCPPQIYLIDLEFGCCSAHAVPELTDGQSFHLALAREDCVYLLGGHIASTDCRPPRLFRVRVELLLGSPL 165
Cdd:pfam03089 117 RTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSLARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPA 196
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563  166 VSCEILNDGLSITSAIATPIGSaHEYIILGGYQSDSQKRLLCTYIGLDDVGIRIEPREPPEWTSEISQSRTWFGGTLAKG 245
Cdd:pfam03089 197 VSCTVLPGGISVSSAIVTQTGS-HEFVIVGGYQSESQKRMVCNTVVLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKG 275
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 109895563  246 SALIVIPTGTNPTPADANYFYQLSFKQ-ERDGEDPTQTCSQEST-DFEDSAPLEDSEELYFGRE 307
Cdd:pfam03089 276 AVLLGIPGDNKQLPSDANYFYQLNFGEdEEEEEQPTQTCSQESTeDQGDSTPFEDSEEFYFSRE 339
 
Name Accession Description Interval E-value
RAG2 pfam03089
Recombination activating protein 2; V-D-J recombination is the combinatorial process by which ...
6-307 0e+00

Recombination activating protein 2; V-D-J recombination is the combinatorial process by which the huge range of immunoglobulin and T cell binding specificity is generated from a limited amount of genetic material. This process is synergistically activated by RAG1 and RAG2 in developing lymphocytes. Defects in RAG2 in humans are a cause of severe combined immunodeficiency B cell negative and Omenn syndrome.


Pssm-ID: 427128  Cd Length: 339  Bit Score: 540.86  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563    6 PECYLIHGGRTPNNELSSSLYLLSVDSRGcNRKVIMRCQEKELVGALPEARYGHTLSVVHSRGKTACVLFGGRSYMPPSE 85
Cdd:pfam03089  38 KEQYLIHGGKTPNNELSDKLYIMSLDSKG-NKKVTLRCTEKELVGDVPEARYGHTISVVYSRGKSACVLFGGRSYMPPGQ 116
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563   86 RTTETWNCMVDCPPQIYLIDLEFGCCSAHAVPELTDGQSFHLALAREDCVYLLGGHIASTDCRPPRLFRVRVELLLGSPL 165
Cdd:pfam03089 117 RTTENWNSVVDCPPQVFLIDLEFGCCTSYTLPELQDGQSFHVSLARNDTVYILGGHSLANNSRPPRLYRLKVDLPLGSPA 196
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 109895563  166 VSCEILNDGLSITSAIATPIGSaHEYIILGGYQSDSQKRLLCTYIGLDDVGIRIEPREPPEWTSEISQSRTWFGGTLAKG 245
Cdd:pfam03089 197 VSCTVLPGGISVSSAIVTQTGS-HEFVIVGGYQSESQKRMVCNTVVLEDNKIEIEERETPDWTPDIKHSKTWFGSSMGKG 275
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 109895563  246 SALIVIPTGTNPTPADANYFYQLSFKQ-ERDGEDPTQTCSQEST-DFEDSAPLEDSEELYFGRE 307
Cdd:pfam03089 276 AVLLGIPGDNKQLPSDANYFYQLNFGEdEEEEEQPTQTCSQESTeDQGDSTPFEDSEEFYFSRE 339
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH